flavoxate has been researched along with atropine in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (40.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Benson, GS; Raezer, DM; Sarshik, SA; Wein, AJ | 1 |
Aoki, K; Kishimoto, T; Naruchi, T; Okamiya, Y; Takeshita, T | 1 |
Kasama, T; Mayuzumi, K; Tamaru, K; Watanabe, K | 1 |
Ito, Y; Kato, H; Morikawa, K; Yamauchi, T | 1 |
Fukui, H; Hamada, K; Kimura, K; Kimura, Y; Nishizawa, O; Sasaki, Y; Sugaya, K; Ukai, Y; Yoshikuni, Y | 1 |
Hamada, K; Kimura, K; Kimura, Y; Sasaki, Y; Seto, T; Ukai, Y; Yamazaki, C; Yoshikuni, Y | 1 |
1 review(s) available for flavoxate and atropine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for flavoxate and atropine
Article | Year |
---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Bladder muscle contractility. Comparative effects and mechanisms of action of atropine, propantheline, flavoxate, and imipramine.
Topics: Animals; Atropine; Barium; Bethanechol Compounds; Chlorides; Dogs; Female; Flavonoids; Flavoxate; Imipramine; In Vitro Techniques; Muscle Contraction; Propantheline; Receptors, Cholinergic; Time Factors; Urinary Bladder | 1977 |
Effects of clenbuterol on resting tension and contractile response in vesicourethral smooth muscle of rabbits.
Topics: Acetylcholine; Adrenergic beta-Agonists; Animals; Atropine; Clenbuterol; Dose-Response Relationship, Drug; Ethanolamines; Flavoxate; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Rabbits; Urethra; Urinary Bladder; Verapamil | 1989 |
[Effects of oxybutynin hydrochloride on the urinary bladder and urethra in in situ preparations].
Topics: Animals; Atropine; Cats; Drug Interactions; Female; Flavoxate; Hypogastric Plexus; Male; Mandelic Acids; Papaverine; Pelvis; Peripheral Nerves; Propantheline; Rabbits; Urethra; Urinary Bladder | 1986 |
[Effects of 3-methyl-4-oxo-2-phenyl-N-[2-piperidinyl) ethyl]-4H-1-benzopyran-8-carboxyamide hydrochloride monohydrate (FL-155), a new anti-pollakiuria agent, on rhythmic bladder contractions in anesthetized rats].
Topics: Animals; Atropine; Flavoxate; Lidocaine; Male; Periodicity; Piperidines; Rats; Rats, Inbred Strains; Reflex; Thiopental; Urinary Bladder; Urination Disorders | 1986 |
Mechanisms of the suppression of the bladder activity by flavoxate.
Topics: Animals; Atropine; Calcium; Carbachol; Cats; Electric Stimulation; Female; Flavoxate; Injections, Intraventricular; Locus Coeruleus; Male; Microinjections; Muscle Contraction; Muscle, Smooth; Neurons, Afferent; Neurons, Efferent; Parasympatholytics; Parasympathomimetics; Peripheral Nerves; Pons; Rats; Rats, Sprague-Dawley; Tegmentum Mesencephali; Urinary Bladder; Urination | 1996 |
Effect of NS-21, an anticholinergic drug with calcium antagonistic activity, on lower urinary tract function in a rat model of urinary frequency.
Topics: Animals; Atropine; Benzilates; Calcium Channel Blockers; Denervation; Disease Models, Animal; Flavoxate; Hypogastric Plexus; Male; Mandelic Acids; Parasympatholytics; Phenylacetates; Rats; Rats, Sprague-Dawley; Urinary Bladder; Urinary Incontinence | 1997 |